STREAM goes Preprint with an Analysis of the Development of the Anti-cancer drug Ixabepilone ift.tt/2yuCcMr
Risk/Benefit in Pediatric Phase 1 Cancer Trials: Noble Lie? (part 2) ift.tt/2taTzCi
Risk/Benefit in Pediatric Phase 1 Cancer Trials: Noble Lie? (part 1) ift.tt/2Clb7PC
STREAM director @KimmelmanJ interviewed regarding transparency in clinical trial reporting reuters.com/article/us-healt… #bioethics
Drug Development at the Portfolio Level, a new paper from @KimmelmanJ and @bgcarlisle
jamanetwork.com/journals/jam…
The Back Story on “Can cancer researchers accurately judge whether preclinical reports will reproduce? ift.tt/2uLALFr
STREAM Research retweeted
Preclinical Cancer Studies Not as Reproducible as Thought | The Scientist Magazine® the-scientist.com/?articles.…
Nonpublication of Neurology Trials for Stalled Drugs & the Ironic Nonpublication of Data on those Stalled Drugs ift.tt/2sa1cXD
Public Perception and Communication of Scientific Uncertainty ift.tt/2rYlMar
Into the Unknown: Methodological and Ethical Issues in Phase I Trials ift.tt/2psd71H
STREAM Research retweeted
"Consider drug efficacy before first-in-human trials" nature.com/news/consider-dru… Nice work, @KimmelmanJ!
STREAM Research retweeted
Great article @KimmelmanJ raises important issues re clinical research (human). xitter.cf/EricTopol/status/82607…
Do we have the proper guard rails for first-in-man clinical trials? nature.com/news/consider-dru… @NatureNews @KimmelmanJ
Congrats to the STREAM team for winning the @PGSS_McGill trivia night!
STREAM Research retweeted
Just arrived in Montreal and looking forward to joining @stream_research here for the next 6 months!
New paper by @KimmelmanJ: Is Participation in Cancer Phase I Trials Really Therapeutic? jco.ascopubs.org/content/ear… #bioethics
Who Cares if the Emperor is Immodestly Attired: An Exploration of the Trustworthiness of Biomedical Research ift.tt/2clCjhM
Accelerated Drug Approval and Health Inequality ift.tt/29PwLPl









